Prevention of Ocular Scarring After Glaucoma Filtering Surgery Using the Monoclonal Antibody LT1009 (Sonepcizumab) in a Rabbit Model

PURPOSE: Excessive scarring leading to failure of the filtering bleb continues to be a major problem after glaucoma filtration surgery. This study examines the antifibrotic effects of the anti-S1P monoclonal antibody LT1009 (Sonepcizumab) in prolonging bleb survival in a rabbit model of glaucoma fil...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lukowski, Zachary L., Min, Jeff, Beattie, Ashley R., Meyers, Craig A., Levine, Monica A., Stoller, Glenn, Schultz, Gregory S., Samuelson, Don A., Sherwood, Mark B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3644983/
https://ncbi.nlm.nih.gov/pubmed/21946553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IJG.0b013e31822e8c83
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller